+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of anticancer agents and scavengers on CMV-promoter-driven exogenous gene expression in genetically modified cells



Effects of anticancer agents and scavengers on CMV-promoter-driven exogenous gene expression in genetically modified cells



Journal of Pharmacy and Pharmacology 61(4): 527-531



This study aimed to investigate whether the levels of rsGFP mRNA and the fluorescence levels of cytomegalovirus (CMV)-promoter-driven rsGFP (red-shifted green fluorescent protein) could be changed by using anticancer agents and also to examine the effects of co-treatment with anticancer agents and scavengers. The pQBI25 vector, which encodes the CMV promoter and the cDNA for rsGFP, was transfected into FR cells (rat skin fibroblast cell line). FR-pQBI25 cells were then exposed to doxorubicin, 5-fluorouracil, methotrexate or paraquat with or without scavengers such as N-acetyl cysteine (NAC) and edaravone for 48 h. The levels of rsGFP mRNA were found to be significantly higher following doxorubicin, 5-fluorouracil and paraquat treatment but were not changed by methotrexate. These levels of rsGFP mRNA were found to be significantly lower after paraquat/edaravone co-treatment compared with paraquat alone. The fluorescence levels of rsGFP were found to be significantly higher following doxorubicin and paraquat treatment but were not changed by 5-fluorouracil and methotrexate. The levels were also found to be significantly lower after paraquat/edaravone co-treatment compared with paraquat alone and also after doxorubicin/NAC co-treatment compared with doxorubicin alone. These findings suggest that CMV-promoter-driven exogenous gene expression may be partly regulated by reactive oxygen species.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052855935

Download citation: RISBibTeXText

PMID: 19298701


Related references

Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells. Journal of Pharmacy and Pharmacology 60(12): 1659-1665, 2008

Exogenous gene expression by genetically modified HaCaT cells accelerating human skin epidermal keratinocyte proliferation. Wound Repair & Regeneration 8(5): A411, September-October, 2000

Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter. Anticancer Research 24(5a): 3075-3079, 2004

Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter. Journal of Biological Chemistry 273(37): 23837-23843, 1998

Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. European Journal of Cancer 40(11): 1787-1794, 2004

Expression of osm gene driven by hTERT gene promoter inhibits cancer cells proliferation in vitro. Ai Zheng 22(6): 575-578, 2003

Exploration of the variance in exogenous gene expression driven by the different promoters in leukemia cells. Yi Chuan 33(8): 879-885, 2011

Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation. Experimental Neurology 166(1): 90-98, 2000

Effects of Different Types of Radiation on HIV Promoter-driven Gene Expression. AMERICAN SOCIETY FOR MICROBIOLOGY [Author] Human retroviruses and related infections : 61, 1995

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene. Oncology Reports 29(4): 1435-1440, 2013

Expression of target gene in eukaryotic cells driven by prokaryotic T7 promoter and its RNA polymerase. Sheng Wu Gong Cheng Xue Bao 21(2): 182-186, 2005

NF-κB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells. Biotechnology Journal 10(7): 1019-1028, 2015

Regulation of C-fos gene expression of the transplanted genetically modified cells in the rat brain. Society for Neuroscience Abstracts 19(1-3): 1317, 1993

Novel anticancer vaccine using genetically modified endothelial cells. European Urology Suppl.s 2(1): 44, 2003